Our Changing World

Dr Claire Concannon follows scientists into the bush, over rivers, back to their labs and many places in-between to cover the most fascinating research being done in Aotearoa New Zealand.

  1. Nov 9

    Earthquake research a decade after Kaikōura

    Ten years after the magnitude 7.8 Kaikōura earthquake, scientists are still learning from this remarkably complex event. Kaikōura challenged earthquake researchers’ understanding of multi-fault earthquakes, pushed rapid response efforts forwards and brought up new questions about slow slip earthquakes. Plus, damage to buildings in Wellington’s CBD brought up new questions about the shape of the sedimentary basin beneath the city and how it acts to amplify ground shaking. Sign up to the Our Changing World monthly newsletter for episode backstories, science analysis and more. LEARN MORE: Revisit the first months of research following the earthquake with this 2017 OCW episode.Learn more about the Hikurangi subduction zone and slow-slip earthquakes.Listen to Underwater slips and slides for more research into geological phenomena that could pose a tsunami risk to Aotearoa.Browse RNZ’s Earthquakes on Our Changing World collection.GUESTS: Dr Anna Kaiser – Chief Scientist, Earthquake Hazards, Earth Sciences New ZealandEmeritus Professor Tim Stern – Te Herenga Waka – Victoria University of WellingtonAlistair Stronach – former master’s student at Te Herenga WakaIN THIS EPISODE: (00:00) Introduction (01:02) Complex, multi-fault earthquakes (05:36) Changes to earthquake hazard modelling (09:50) The impacts in Wellington (14:34) Modeling the sedimentary basin (21:32) The basin edge effect (24:28) Reflections a decade on Go to this episode on rnz.co.nz for more details

  2. Oct 12

    Are GLP1 drugs worth the hype?

    GLP1 - RA weight loss drugs get the Our Changing World treatment! What are they? How do they work? And what does the science say about the benefits, and the risks? Plus, beyond health outcomes, how might things change as they become more widely available? Sign up to the Our Changing World monthly newsletter here for episode backstories, science analysis and more. LEARN MORE: If you’d like a deeper understanding of how drugs such as Ozempic and Wegovy affect appetite and blood sugar regulation, Emile Donovan spoke to Dr Sebastian Furness about this on Nights.Obesity genetics researcher Giles Yeo joined Afternoons to explain why body weight is influenced by much more than willpower, and why biology plays such a powerful role in hunger and weight regulation.The study that Dr Andrew Reynolds contributed to on how obesity trends are changing around the world was published in Nature. You can read the paper here.Curious about how the major incretin drugs compare? This systematic review and meta-analysis examines the effectiveness of semaglutide, liraglutide, dulaglutide and tirzepatide for blood sugar control and other outcomes.GUESTS: Dr Andrew Reynolds, Department of Medicine, University of OtagoIN THIS EPISODE: (00:00) Introduction (01:12) How GLP-1 receptor agonists were developed as treatments for type 2 diabetes (03:55) The biology of incretins, insulin, glucagon and how these drugs work (07:20) The drugs available and funded in New Zealand (11:34) Weight loss benefits, side effects and questions about long-term use (20:30) Retatrutide, future incretin therapies and the emerging “Ozempic economy” Go to this episode on rnz.co.nz for more details

4.8
out of 5
24 Ratings

About

Dr Claire Concannon follows scientists into the bush, over rivers, back to their labs and many places in-between to cover the most fascinating research being done in Aotearoa New Zealand.

More From RNZ Originals

You Might Also Like